 SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 GLOBE NEWSWIRE -- Catalyst Biosciences, Inc. NASDAQ: CBIO today announced that its chief financial officer, Clinton Musil, has resigned for personal reasons effective October 29, 2021. Seline Miller, the Companys controller, has been promoted to senior vice president, finance and will serve as interim chief financial and principal accounting officer while the Company initiates a search for a successor. 